Serveur d'exploration Tocilizumab - Analysis (France)

Index « AbsEn.i » - entrée « diseases »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
diseased < diseases < dislocation  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 82.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000010 (2020) Eric Toussirot [France]The Interrelations between Biological and Targeted Synthetic Agents Used in Inflammatory Joint Diseases, and Obesity or Body Composition
000029 (2020) Christophe Richez [France] ; Estibaliz Lazaro [France] ; Maël Lemoine [France] ; Marie-Elise Truchetet [France] ; Thierry Schaeverbeke [France]Implications of COVID-19 for the management of patients with inflammatory rheumatic diseases
000037 (2020) Martin Michaud [France] ; Olivier Lidove [France] ; Boris Bienvenu [France] ; Laurent Chiche [France] ; Geoffrey Urbanski [France]Effectiveness and tolerance of off-label use of tocilizumab in autoimmune diseases: A Multicenter Study.
000041 (2020) Robert David Sandler [Royaume-Uni] ; Rachel Scarlett Tattersall [Royaume-Uni] ; Helene Schoemans [Belgique] ; Raffaella Greco [Italie] ; Manuela Badoglio [France] ; Myriam Labopin [France] ; Tobias Alexander [Allemagne] ; Kirill Kirgizov [Russie] ; Montserrat Rovira [Espagne] ; Muhammad Saif [Royaume-Uni] ; Riccardo Saccardi [Italie] ; Julio Delgado [Espagne] ; Zinaida Peric [Croatie] ; Christian Koenecke [Allemagne] ; Olaf Penack [Allemagne] ; Grzegorz Basak [Pologne] ; John Andrew Snowden [Royaume-Uni]Diagnosis and Management of Secondary HLH/MAS Following HSCT and CAR-T Cell Therapy in Adults; A Review of the Literature and a Survey of Practice Within EBMT Centres on Behalf of the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP)
000042 (2020) Kassandra Lanchais ; Frederic Capel ; Anne Tournadre [France]Could Omega 3 Fatty Acids Preserve Muscle Health in Rheumatoid Arthritis?
000045 (2020) Charlotte Laurent [France] ; Zora Marjanovic [France] ; Laure Ricard [France] ; Joerg Henes [Allemagne] ; Remy Dulery [France] ; Manuela Badoglio [France] ; Dominique Farge [France] ; John A. Snowden [Royaume-Uni] ; Daniela Moraes [Brésil] ; Juliana Dias [Brésil] ; Mohamad Mohty [France] ; Michael Soussan [France] ; Olivier Fain [France] ; Renate Arnold [Allemagne] ; Tobias Alexander [Allemagne] ; Maria-Carolina Oliveira [Brésil] ; Arsène Mekinian [France]Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in refractory Takayasu arteritis: a retrospective multicenter case-series from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT).
000047 (2020) Julianne Duhazé [Canada, France] ; Signe H Ssler [France] ; Delphine Bachelet [France] ; Aude Gleizes [France] ; Salima Hacein-Bey-Abina [France] ; Matthieu Allez [France] ; Florian Deisenhammer [Autriche] ; Anna Fogdell-Hahn [Suède] ; Xavier Mariette [France] ; Marc Pallardy [France] ; Philippe Broët [Canada, France]A Machine Learning Approach for High-Dimensional Time-to-Event Prediction With Application to Immunogenicity of Biotherapies in the ABIRISK Cohort
000055 (2019) Guillaume Rollin [France] ; José Lages [France] ; Dima L. Shepelyansky [France]Wikipedia network analysis of cancer interactions and world influence
000063 (2019) Luc Rochette ; Alexandre Meloux ; Eve Rigal ; Marianne Zeller ; Yves Cottin [France] ; Catherine VergelyThe Role of Osteoprotegerin and Its Ligands in Vascular Function
000066 (2019) Emmanuel Andrès [France] ; Noel Lorenzo Villalba [France] ; Abrar-Ahmad Zulfiqar [France] ; Khalid Serraj [Maroc] ; Rachel Mourot-Cottet [France] ; Jacques-Eric Gottenberg [France]State of Art of Idiosyncratic Drug-Induced Neutropenia or Agranulocytosis, with a Focus on Biotherapies
000067 (2019) Natalia Cabrera [France] ; Jean-Christophe Lega [France] ; Behrouz Kassai [France] ; Carine Wouters [Belgique] ; Anuela Kondi [France] ; Elvira Cannizzaro [Suisse] ; Andreas Woerner [Suisse] ; Aurelie Chausset [France] ; Samuel Roethlisberger [Suisse] ; Cyril Jeanneret [Suisse] ; Florence Aeschlimann [Suisse] ; Salma Malik [France] ; Agnès Duquesne [France] ; Daniela Kaiser [Suisse] ; Laetitia Higel [France] ; Anne Maes [Belgique] ; Gerald Berthet [Suisse] ; Veronique Hentgen [France] ; Isabelle Kone-Paut [France] ; Alexandre Belot [France] ; Michael Hofer [Suisse]Safety of biological agents in paediatric rheumatic diseases: A real-life multicenter retrospective study using the JIRcohorte database.
000079 (2019) Fabienne Coury [France] ; Olivier Peyruchaud [France] ; Irma Machuca-Gayet [France]Osteoimmunology of Bone Loss in Inflammatory Rheumatic Diseases
000102 (2019) Natalie A. Prow [Australie] ; Thiago D. C. Hirata [Brésil] ; Bing Tang [Australie] ; Thibaut Larcher [France] ; Pamela Mukhopadhyay [Australie] ; Tiago Lubiana Alves [Brésil] ; Thuy T. Le [Australie] ; Joy Gardner [Australie] ; Yee Suan Poo [Australie] ; Eri Nakayama [Australie, Japon] ; Viviana P. Lutzky [Australie] ; Helder I. Nakaya [Brésil] ; Andreas Suhrbier [Australie]Exacerbation of Chikungunya Virus Rheumatic Immunopathology by a High Fiber Diet and Butyrate
000105 (2019) Christien Rondaan [Pays-Bas] ; Victoria Furer [Israël] ; Marloes W. Heijstek [Pays-Bas] ; Nancy Agmon-Levin [Israël] ; Marc Bijl [Pays-Bas] ; Ferdinand C. Breedveld [Pays-Bas] ; Raffaele D Melio [Italie] ; Maxime Dougados [France] ; Meliha C. Kapetanovic [Suède] ; Jacob M. Van Laar [Pays-Bas] ; Annette Ladefoged De Thurah [Danemark] ; Robert Landewé [Pays-Bas] ; Anna Molto [France] ; Ulf Müller-Ladner [Allemagne] ; Karen Schreiber [Royaume-Uni, Danemark] ; Leo Smolar [Israël] ; Jim Walker ; Klaus Warnatz [Allemagne] ; Nico M. Wulffraat [Pays-Bas] ; Sander Van Assen [Pays-Bas] ; Ori Elkayam [Israël]Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations
000143 (2018) X. Grimaux [France] ; S. Leducq [France] ; P. Goupille [France] ; A. Aubourg [France] ; E. Miquelestorena-Standley [France] ; M. Samimi [France][Aphthous mouth ulcers as an initial manifestation of sécukinumab-induced inflammatory bowel disease].
000144 (2018) Armando Andres Roca Suarez [France] ; Nicolaas Van Renne [France] ; Thomas F. Baumert [France] ; Joachim Lupberger [France]Viral manipulation of STAT3: Evade, exploit, and injure
000168 (2018) Roberto Patern [Italie] ; Jean-Marc Chillon [France]Potentially Common Therapeutic Targets for Multiple Sclerosis and Ischemic Stroke
000192 (2018) Anna Ohradanova-Repic [Autriche] ; Christian Machacek [Autriche] ; Celine Charvet [France] ; Franck Lager [France] ; Delphine Le Roux [France] ; René Platzer [Autriche] ; Vladimir Leksa [Autriche, Slovaquie] ; Goran Mitulovic [Autriche] ; Thomas R. Burkard [Autriche] ; Gerhard J. Zlabinger [Autriche] ; Michael B. Fischer [Autriche] ; Vincent Feuillet [France] ; Gilles Renault [France] ; Stephan Blüml [Autriche] ; Miroslav Benko ; Miloslav Suchanek ; Johannes B. Huppa [Autriche] ; Takami Matsuyama [Japon] ; Artur Cavaco-Paulo [Portugal] ; Georges Bismuth [France] ; Hannes Stockinger [Autriche]Extracellular Purine Metabolism Is the Switchboard of Immunosuppressive Macrophages and a Novel Target to Treat Diseases With Macrophage Imbalances
000198 (2018) K L Winthrop [États-Unis] ; X. Mariette [France] ; J T Silva [Espagne] ; E. Benamu [États-Unis] ; L H Calabrese [États-Unis] ; A. Dumusc [Suisse] ; J S Smolen [Autriche] ; J M Aguado [Espagne] ; M. Fernández-Ruiz [Espagne]ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors).
000199 (2018) Alain Lescoat [France] ; Alice Ballerie [France] ; Yu Augagneur ; Claudie Morzadec ; Laurent Vernhet ; Olivier Fardel [France] ; Patrick Jégo [France] ; Stéphane Jouneau [France] ; Valérie LecureurDistinct Properties of Human M-CSF and GM-CSF Monocyte-Derived Macrophages to Simulate Pathological Lung Conditions In Vitro: Application to Systemic and Inflammatory Disorders with Pulmonary Involvement
000202 (2018) Tamas Constantin [Hongrie] ; Ivan Foeldvari [Allemagne] ; Jordi Anton [Espagne] ; Joke De Boer [Pays-Bas] ; Severine Czitrom-Guillaume [France] ; Clive Edelsten [Royaume-Uni] ; Raz Gepstein [Israël] ; Arnd Heiligenhaus [Allemagne] ; Clarissa A. Pilkington [Royaume-Uni] ; Gabriele Simonini [Italie] ; Yosef Uziel [Israël] ; Sebastian J. Vastert [Pays-Bas] ; Nico M. Wulffraat [Pays-Bas] ; Anne-Mieke Haasnoot [Pays-Bas] ; Karoline Walscheid [Allemagne] ; Annamária Pálinkás [Hongrie] ; Reshma Pattani [Royaume-Uni] ; Zoltán Györgyi [Hongrie] ; Richárd Kozma [Hongrie] ; Victor Boom [Pays-Bas] ; Andrea Ponyi [Hongrie] ; Angelo Ravelli [Italie] ; Athimalaipet V. Ramanan [Royaume-Uni]Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/AbsEn.i -k "diseases" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/AbsEn.i  \
                -Sk "diseases" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    diseases
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021